Abstract: Techniques are provided for dynamically generating content. A request for content about a first entity is received from a client device. In response to receiving the request, an identity of a second entity of the client device is determined. Based on the identity, attributes of the second entity are identified. It is determined whether the attributes satisfy targeting criteria of a campaign that was initiated by the first entity. In response to determining that the attributes satisfy the targeting criteria, a first number of entities that (i) share one or more attributes in common with the second entity and (ii) satisfy the targeting criteria is determined. Also, a second number of entities that share the one or more attributes in common with the second entity is determined. A ratio is calculated based on the two numbers. First content that specifies the ratio is sent to the client device for display.

Abstract: Techniques are provided for dynamically generating content. A request for content about a first entity is received from a client device. In response to receiving the request, an identity of a second entity of the client device is determined. Based on the identity, attributes of the second entity are identified. It is determined whether the attributes satisfy targeting criteria of a campaign that was initiated by the first entity. In response to determining that the attributes satisfy the targeting criteria, a first number of entities that (i) share one or more attributes in common with the second entity and (ii) satisfy the targeting criteria is determined. Also, a second number of entities that share the one or more attributes in common with the second entity is determined. A ratio is calculated based on the two numbers. First content that specifies the ratio is sent to the client device for display.

Abstract: Disclosed are PAP mutants that are less toxic than wild type PAP and that exhibit depurination activity. Also disclosed are transgenic plants that produce the PAP mutants, and methods for preparing the plants. Further disclosed are bioconjugates containing the PAP mutants, pharmaceutical compositions containing the bioconjugates, and methods of administering the compositions to treat disease.

Abstract: Disclosed are PAP mutants that are less toxic than wild type PAP and that exhibit depurination activity. Also disclosed are transgenic plants that procedure the PAP mutants, and methods for preparing the plants. Further disclosed are bioconjugates containing the PAP mutants, pharmaceutical compositions containing the bioconjugates, and methods of administering the compositions to treat disease.

Abstract: Disclosed are PAP mutants that are less toxic than wild type PAP and that exhibit depurination activity. Also disclosed are transgenic plants that procedure the PAP mutants, and methods for preparing the plants. Further disclosed are bioconjugates containing the PAP mutants, pharmaceutical compositions containing the bioconjugates, and methods of administering the compositions to treat disease.